JSW Dulux Limited (formerly Akzo Nobel India Limited) conducted a group investor conference call on 14 May 2026 at 09:00 hrs, in compliance with Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call was addressed by the company's senior management and focused on the financial results for the quarter and year ended 31 March 2026, with an opportunity for investors to address queries.

Conference Call Details

The key details of the investor conference call are summarised below:

Investor Presentation and Audio Recording

Prior to the conference call, a presentation for investors was shared with the stock exchanges and uploaded on the company's website. An audio recording of the call is available on the company website and can be accessed at https://akzonobel.co.in/investors.php#im . The company has also noted that the transcript of the call will be shared with the stock exchanges and posted on the company website within the stipulated timeline, in accordance with applicable regulatory requirements.

Regulatory Compliance

The disclosure was made by Rajiv L. Jha, General Counsel & Company Secretary of JSW Dulux Limited, confirming that the group conference call outcome has been duly intimated to both BSE Limited and the National Stock Exchange of India Ltd. as required under the relevant SEBI listing regulations.

The Nomination and Remuneration Committee (NRC) of JSW Dulux Limited (formerly Akzo Nobel India Limited) approved the grant of 2,57,682 employee stock options (ESOPs) to eligible employees at its meeting held on May 13, 2026. The grant has been made under the JSW Dulux Limited - Employee Stock Option Scheme 2026 (ESOP 2026), which has been approved by the shareholders of the company. The disclosure has been made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the ESOP Grant

The following table summarises the key parameters of the ESOP grant as disclosed by the company:

Exercise Price Determination

The exercise price of Rs. 2922.80 per option has been determined as the Market Price under ESOP 2026. As defined in the scheme, Market Price refers to the latest available closing price on the stock exchange on which the shares of the company are listed, on the date immediately prior to the relevant date. Accordingly, the exercise price has been based on the closing price of the company's shares on the National Stock Exchange of India Limited (NSE) on May 12, 2026, being the exchange where the highest trading volumes were recorded on that date.

Vesting and Exercise Period

The options granted under ESOP 2026 are subject to a vesting schedule and exercise period as outlined below:

• Minimum Vesting Period: 1 (One) year from the date of grant
• Maximum Vesting Period: 5 (Five) years from the date of grant
• Exercise Period: A maximum of 4 (Four) years commencing from the date of each vesting
• Special Circumstances: In the event of death or permanent incapacity, the NRC may, at its discretion, allow an additional exercise period not exceeding 12 months beyond the originally prescribed exercise period
• Flexibility: All vested options may be exercised by the option grantee at one time or at various points within the exercise period

Scheme Administration and Governance

The ESOP 2026 is administered and supervised by the Nomination and Remuneration Committee, which holds all rights, powers, and duties relating to the scheme, including those delegated by the Board in accordance with applicable laws. The scheme is also administered by a Trust to the extent aspects of such administration are delegated by the Committee as per applicable legal requirements. All questions of interpretation of the scheme are to be determined by the Committee, and such determinations are final and binding on all persons having an interest in the scheme.

Each ESOP, when exercised, will be converted into one equity share of the company with a face value of Rs. 10/- (Rupees Ten only), fully paid-up. The company has stated that diluted earnings per share pursuant to the issue of equity shares on exercise of options is not applicable at this stage. The intimation has been signed by Rajiv L. Jha, General Counsel & Company Secretary, and the relevant information is also available on the company's website at www.akzonobel.co.in .